Show simple item record

dc.contributor.authorKozajda, Anna
dc.date.accessioned2018-12-03T09:32:31Z
dc.date.available2018-12-03T09:32:31Z
dc.date.issued2018-08-20
dc.identifier.citationMed Pr 2018, 69 (4):413-424en
dc.identifier.issn0465-5893
dc.identifier.pmid30010161
dc.identifier.doi10.13075/mp.5893.00728
dc.identifier.urihttp://hdl.handle.net/10146/618214
dc.description.abstractPaper presents the intentional use of biological agents for industrial, diagnostic and research purposes in enterprises in Poland.
dc.description.abstractThe source of data is the National Register of Biological (in Polish KRCB) - the type of the database that gathers data about the intentional use of biological agents at work in Poland. The analysis includes tabular summaries of the data as of December 2017.
dc.description.abstractNotifications were sent by 598 enterprises for: diagnostic - 67.5%, research - 25% and industrial purposes - 75%. Those mostly were hospital diagnostic laboratories - 36%, entities other than hospitals - 32% and higher education and research units - 13%. In total, 4477 workers (91.3% women, 8.7% men) were exposed to biological agents. Agents from 2nd and 3rd group of risk were used in 581 and 106 enterprises, respectively. Escherichia coli bacteria was most frequently used (with the exception of non-pathogenic strains) in 504 enterprises (3529 exposed workers), Staphylococcus aureus - 495 enterprises (3464 workers) and Pseudomonas aeruginosa - 459 enterprises (3157 workers). In 58 enterprises, biological agents recognized by the International Agency for Research on Cancer as carcinogenic were used (viruses: hepatitis B virus (HBV) - 10 enterprises and 257 workers, hepatitis C virus (HCV) - 10 enterprises and 232 workers, Epstein-Barr virus (EBV) - 9 enterprises and 227 workers, human immunodeficiency virus type 1 (HIV-1) - 8 enterprises and 186 workers, human papilloma virus (HPV) - 3 enterprises and 94 workers, human herpes virus type 8 (HHV-8) - 3 enterprises and 22 workers, human T-lymphotropic virus type 1 (HTLV-1) - 1 enterprise and 17 workers; parasites: Schistosoma haematobium - 2 enterprises and 4 workers, Clonorchis viverrini - 1 enterprises and 2 workers, Clonorchis sinensis - 1 enterprises and 2 workers; bacteria: Helicobacter pylori - 10 enterprises and 137 workers).
dc.description.abstractThe network organization, legal base and central nature cause that the KRCB is a unique database that allows for diagnosis of the situation and tracking of dynamics in the context of occupational exposure to biological agents used intentionally in enterprises in Poland. Med Pr 2018;69(4):413-424.
dc.languagepol
dc.language.isoplen
dc.relation.urlhttp://medpr.imp.lodz.pl/Celowe-uzycie-czynnikow-biologicznych-w-Polsce-na-podstawie-danych-z-Krajowego-Rejestru,85648,0,1.htmlen
dc.rightsArchived with thanks to Medycyna pracyen
dc.rights.urihttp://creativecommons.org/licenses/by-nc/4.0/*
dc.subjectbiohazarden
dc.subjectcarcinogenic biological agentsen
dc.subjectintentional use of biological agentsen
dc.subjectoccupational exposureen
dc.subjectoccupational exposure to biological agentsen
dc.subjectregister of biological agentsen
dc.title[Biological agents intentionally used in Poland based on data from the National Register Of Biological Agents].pl
dc.title.alternativeCelowe użycie czynników biologicznych w Polsce na podstawie danych z Krajowego Rejestru Czynników Biologicznychen
dc.typeArticleen
dc.contributor.departmentNofer Institute of Occupational Medicineen
dc.identifier.journalMedycyna Pracyen
refterms.dateFOA2018-12-17T18:10:19Z
html.description.abstractPaper presents the intentional use of biological agents for industrial, diagnostic and research purposes in enterprises in Poland.
html.description.abstractThe source of data is the National Register of Biological (in Polish KRCB) - the type of the database that gathers data about the intentional use of biological agents at work in Poland. The analysis includes tabular summaries of the data as of December 2017.
html.description.abstractNotifications were sent by 598 enterprises for: diagnostic - 67.5%, research - 25% and industrial purposes - 75%. Those mostly were hospital diagnostic laboratories - 36%, entities other than hospitals - 32% and higher education and research units - 13%. In total, 4477 workers (91.3% women, 8.7% men) were exposed to biological agents. Agents from 2nd and 3rd group of risk were used in 581 and 106 enterprises, respectively. <i>Escherichia coli</i> bacteria was most frequently used (with the exception of non-pathogenic strains) in 504 enterprises (3529 exposed workers), <i>Staphylococcus aureus</i> - 495 enterprises (3464 workers) and <i>Pseudomonas aeruginosa</i> - 459 enterprises (3157 workers). In 58 enterprises, biological agents recognized by the International Agency for Research on Cancer as carcinogenic were used (viruses: hepatitis B virus (HBV) - 10 enterprises and 257 workers, hepatitis C virus (HCV) - 10 enterprises and 232 workers, Epstein-Barr virus (EBV) - 9 enterprises and 227 workers, human immunodeficiency virus type 1 (HIV-1) - 8 enterprises and 186 workers, human papilloma virus (HPV) - 3 enterprises and 94 workers, human herpes virus type 8 (HHV-8) - 3 enterprises and 22 workers, human T-lymphotropic virus type 1 (HTLV-1) - 1 enterprise and 17 workers; parasites: <i>Schistosoma haematobium</i> - 2 enterprises and 4 workers, <i>Clonorchis viverrini</i> - 1 enterprises and 2 workers, <i>Clonorchis sinensis</i> - 1 enterprises and 2 workers; bacteria: <i>Helicobacter pylori</i> - 10 enterprises and 137 workers).
html.description.abstractThe network organization, legal base and central nature cause that the KRCB is a unique database that allows for diagnosis of the situation and tracking of dynamics in the context of occupational exposure to biological agents used intentionally in enterprises in Poland. Med Pr 2018;69(4):413-424.


Files in this item

Thumbnail
Name:
Biological agents.pdf
Size:
362.4Kb
Format:
PDF

This item appears in the following Collection(s)

Show simple item record

Archived with thanks to Medycyna pracy
Except where otherwise noted, this item's license is described as Archived with thanks to Medycyna pracy